As the hay fever season spreads throughout the UK, millions of individuals are turning to familiar allergy medications to alleviate symptoms like sneezing, itchy eyes, and runny noses. However, concerns have been raised by experts regarding a commonly used medication and its potential connection to a severe long-term health issue.
The medication under scrutiny is Benadryl, a popular antihistamine available in pharmacies and supermarkets. While many people use it safely for short-term relief, studies have indicated that prolonged usage of certain components may be linked to a significantly increased risk of dementia in the future.
According to NHS, antihistamines like Benadryl are effective in treating allergies, insect bites, and hay fever symptoms. Some variations can also induce drowsiness, accompanied by side effects such as dry mouth, dizziness, and difficulty concentrating.
The concern revolves around older-style antihistamines containing anticholinergic drugs, which function by inhibiting acetylcholine, a neurotransmitter crucial for memory and learning processes.
Benadryl products in the US typically contain diphenhydramine, while in the UK, some Benadryl versions contain acrivastine or cetirizine, depending on the formulation.
Research highlighted by Harvard Health revealed that individuals using potent anticholinergic drugs for three years or more had a 54% higher risk of dementia compared to those using them for a shorter duration. The study, published in JAMA Internal Medicine, involved nearly 3,500 adults aged 65 and above.
Harvard Health pointed out that diphenhydramine, found in some Benadryl products, is among the anticholinergic medications associated with the heightened risk. However, researchers emphasized that the findings indicated an association rather than conclusive evidence that the drugs directly cause dementia.
The NHS advises that older individuals might be more sensitive to antihistamines, experiencing side effects like confusion or drowsiness. Health guidance also warns that certain antihistamines can interact with other medications or exacerbate specific medical conditions such as glaucoma and urinary retention issues.
Another report from Harvard Health indicated that anticholinergic drugs could impact the brain by obstructing signals crucial for cognition and memory. Specialists added that the concurrent use of multiple anticholinergic medicines could further elevate the risk.
The Alzheimer’s Society highlighted the need for further research to fully comprehend the link between anticholinergic drugs and dementia. It recommended individuals concerned about medication side effects to consult with a GP or pharmacist before altering their treatment.
Health experts emphasized that abruptly discontinuing prescribed medications without medical advice is not advisable. Individuals seeking regular allergy relief may consider discussing newer non-drowsy antihistamines or alternative treatments with a healthcare provider.